Magnifying LeNS Archives - Page 6 of 7

A New Look at Targeted Therapies for 2021 and Beyond

Bethany Johnson (GO2 for Lung Cancer)2021-10-28T14:59:01-05:00October 28th, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

Authors: Daniel A. Saez, MSc, Treatment and Trials Navigator, GO2 for Lung Cancer and Jacinta R. Wiens, PhD, Director of Lung Cancer Registry, GO2 for Lung Cancer The World Conference on Lung Cancer (WCLC) highlighted many up-and-coming treatments for [...]

0

A Look at Immunotherapies from the World Conference on Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2021-10-29T10:30:06-05:00October 28th, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

Author: Andrew Ciupek, PhD, Senior Manager of Clinical Research, GO2 for Lung Cancer The 2021 World Conference on Lung Cancer (WCLC) saw several research presentations that helped increase our understanding of immunotherapy as a treatment for people with lung [...]

0

Ensuring Health Equity in Cancer Care

Bethany Johnson (GO2 for Lung Cancer)2021-07-21T14:56:26-05:00July 21st, 2021|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

By Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer “Equity: Every Patient. Every Day. Everywhere.” That was the theme for this year’s American Society for Clinical Oncology (ASCO) Annual Meeting. And, indeed, the theme of health equity [...]

0

New Research Unlocks Promise for Treating Small Cell Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:53:22-05:00July 21st, 2021|Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung Cancer Unlocking the Biology of SCLC Patients with small cell lung cancer (SCLC) receive one-size-fits-all treatment because of limited knowledge about the biology of the disease. There are [...]

0

Adding New Drugs to Treatment for Early Stage Lung Cancer

Bethany Johnson (GO2 for Lung Cancer)2021-07-21T14:51:21-05:00July 21st, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

By Jennifer C. King, PhD, Chief Scientific Officer, GO2 for Lung Cancer Surgery has been the primary treatment for early stage non-small cell lung cancer (NSCLC). Unfortunately, many people have seen their cancer come back after surgery. Now researchers [...]

0

New Targeted Therapies in the Biomarker Space

Bethany Johnson (GO2 for Lung Cancer)2021-07-21T14:57:39-05:00July 21st, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

By Andrew Ciupek, PhD, Senior Manager, Clinical Research, GO2 for Lung Cancer and Daniel A. Saez, MSc, Navigator, Treatment & Trials, GO2 for Lung CancerNew Hope for Patients with KRASUntil recently, the KRAS mutation was considered un-targetable in most types [...]

0

Revisiting EGFR

Bethany Johnson (GO2 for Lung Cancer)2021-07-21T14:57:51-05:00July 21st, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

By Andrew Ciupek, PhD, Senior Manager, Clinical Research, GO2 for Lung CancerA number of studies presented at the American Society of Clinical Oncology’s (ASCO) Annual Meeting related to the treatment of non-small cell lung cancer (NSCLC) with an EGFR mutation.Tagrisso [...]

0

Immunotherapy Update

Bethany Johnson (GO2 for Lung Cancer)2021-07-21T14:57:25-05:00July 21st, 2021|Magnifying LeNS, Newsletter Articles, Science and Research|

By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung CancerChemotherapy has been the standard treatment option for Non-Small Cell Lung Cancer (NSCLC) without actionable biomarkers. Recently, immunotherapy treatments have been added into the treatment mix. Several studies presented [...]

0

A Primer on Small Cell Lung Cancer and the Role of Clinical Trials in Treatment

Bethany Johnson (GO2 for Lung Cancer)2023-09-20T12:46:14-05:00April 13th, 2021|Magnifying LeNS, Newsletter Articles, Science and Research, Small Cell Lung Cancer|

By Rashmi Acharya, MS, Coordinator, Science & Research, GO2 for Lung Cancer 1. What is Small Cell Lung Cancer? Small cell lung cancer (SCLC) is a type of lung cancer named for the very small, oval shaped cancer cells [...]

0

Why are Young People Getting Lung Cancer?

Bethany Johnson (GO2 for Lung Cancer)2021-04-13T08:55:57-05:00April 13th, 2021|Hot Topics, Magnifying LeNS, Newsletter Articles, Science and Research|

GO2 for Lung Cancer and the Addario Lung Cancer Medical Institute (ALCMI) recently launched a new study, Epidemiology of Young Lung Cancer (EoYLC), to better understand why some people under the age of 40 develop lung cancer. Many [...]

0